Press "Enter" to skip to content

New patent for Esperion Theraps drug NEXLETOL

1
Copyright © DrugPatentWatch. Originally published at New patent for Esperion Theraps drug NEXLETOL

Annual Drug Patent Expirations for NEXLETOL
Annual Drug Patent Expirations for NEXLETOL

Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug.

NEXLETOL drug price trends.

This drug has twenty patent family members in thirteen countries.

The generic ingredient in NEXLETOL is bempedoic acid. Additional details are available on the bempedoic acid profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Esperion Theraps drug NEXLETOL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions